This year we are celebrating 25 years of smarter studies, global impact, and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements.
Latest News
TB-CHAMP trial finds first-ever safe and effective treatment to prevent multidrug-resistant TB in children
The trial found that levofloxacin, taken for six months once daily, substantially reduced the risk of developing drug-resistant TB.
19 Dec
'25 at 25': Extending the use of drugs - repurposing and beyond
As the final instalment of our 25 at 25 series, we look back at some of the successes of trials we have run that have tested using drugs beyond their original licence.
16 Dec
'25 at 25': PROUD - preventing HIV infections
We look back on the remarkable success of the PROUD study as part of our ’25 at 25’ series celebrating the MRC Clinical Trials Unit’s 25th anniversary.
02 Dec
How people from the LGBT+ community contributed to HIV research
This World AIDS Day, read Sheena McCormack’s story of how she became involved in HIV research and learn about key breakthroughs in the field.
29 Nov
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes